DCGIs

A day after India’s drug regulator approved Covovax for restricted emergency use in children aged 7 to 11 years, the vaccine maker Serum Institute has written to the Centre seeking its inclusion in the national COVID-19 vaccination…

Recently, Serum Institute of India sought approval for Covishield as a booster dose citing adequate stock and a demand for a booster shot due to the emergence of new variants. Dr Reddy’s Laboratories has sought permission from India’s drug…

New Delhi, December 1 Serum Institute of India has sought from India’s drug regulator approval for Covishield as a booster dose citing adequate stock of the vaccine in the country and a…